Pure Global

SARS-CoV-2 IgM IgG Antibody Assay Kit - India CDSCO Medical Device Registration

SARS-CoV-2 IgM IgG Antibody Assay Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000383_404728f8ee3d1bced90b3fced7b8ba26_2ffb2111993f631321bf183a0dbe94fb. This device is marketed under the brand name Immunofluorescence. The license holder is BIODX HEALTHCARE, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
SARS-CoV-2 IgM IgG Antibody Assay Kit
UID: IMP/IVD/2020/000383_404728f8ee3d1bced90b3fced7b8ba26_2ffb2111993f631321bf183a0dbe94fb

Brand Name

Immunofluorescence

License Holder

BIODX HEALTHCARE

Device Class

Class C

Approving Authority

CDSCO

Product Information

qualitative detection of specific IgM antibodies and IgG antibodies against novel coronavirus (Immunofluorescence) in human specimens (Immunofluorescence)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing